Drug Database
Back to search

Ireland· IE-PA-PA0678/153/001

Robitussin Chesty Cough 100 mg/5 ml Oral Solution

A guaifenesin product containing guaifenesin, registered in Ireland by Haleon Ireland Limited. The same ATC class is registered in 14 of our 19 countries.

ATC R05CA03

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedRobitussin Chesty Cough 100 mg/5 ml O…ATCR05CA03REGISTER NO.IE-PA-PA0678/153/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about guaifenesinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Guaifenesin is registered in 14 of 19 countries.

Countries holding a registration under ATC R05CA03 (guaifenesin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 9 of them publish a price we can compare per daily dose
Search guaifenesin products by name

Guaifenesin · ATC R05CA03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of guaifenesin costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Guaifenesin · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

  • US United States$0.29 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Guaifenesin
Manufacturer
Haleon Ireland Limited
Country
Ireland (IE)
ATC code
R05CA03
ATC class
Guaifenesin
Defined daily dose
0.9 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0678/153/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Guaifenesin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All guaifenesin products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Bronchostop Akut, Grippostad Guaifenesin
  • Belgium · Bronchosedal Mucus Honig & Zitrone, Bronchosedal Mucus Honing & Citroen
  • Cyprus · Benylin Mucus Cough Warm Honey & Lemon Flavour
  • Czechia · Guajacuran, Medexpecto Vicks Sirup Med A Zázvor
  • Germany · Fagusan, Wick Husten-Löser Mit Honigaroma
  • Denmark · Benysine
  • Estonia · Expexin
  • Spain · Formulaexpec, Frispec
  • France · Vicks Expectorant Adultes Miel
  • United Kingdom (Northern Ireland) · Bell’s Healthcare Mucus Cough, Benylin Children's Chesty Coughs
  • Greece · Hexacough Warm Honey & Lemon
  • Hungary · Relaxil-G, Robitussin Expectorans
  • Iceland · Túfen
  • Italy · Actigrip Tosse Mucolitico "gusto Mentolo”, Vicks Tosse Fluidificante
  • Lithuania · Expexin
  • Luxembourg · Bronchosedal Mucus Menthol, Bronchosedal Mucus Miel & Citron
  • Latvia · Expexin
  • Norway · Benysine Med Honning- Og Sitronsmak, Solvipect
  • Poland · Guajazyl, Robitussin Expectorans
  • Portugal · Vicks Expectorante Mel
  • Romania · Robitussin Expectorans, Vicks Expectorant
  • Sweden · Nipenesin, Nipenesin Mentol
  • Slovakia · Guajacuran, Robitussin Expectorans Na Vykašliavanie

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd998d68-16ad-42b5-a309-6e932a61b6cb
GET /v1/drugs/bd998d68-16ad-42b5-a309-6e932a61b6cb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral solution",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "R05CA",
    "R05CA03"
  ],
  "strength": null,
  "pa_number": "PA0678/153/001",
  "substances": [
    "Guaifenesin"
  ],
  "legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/04/1983",
  "dispensing_status": "Product not subject to medical prescription",
  "registration_status": "AU",
  "supply_legal_status": "Supply through non-pharmacy outlets and pharmacies",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about guaifenesin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console